Lupus & antiphospholipid syndrome

Thirty-year trajectory of organ damage accrual and damage-free survival in Colombian patients with systemic lupus erythematosus: A registry-based retrospective follow-up study

LupusPublished Retrospective cohort study

Authors' conclusion

The trajectory of organ damage accrual underscores the long-term burden of SLE and the need for comprehensive interventions, particularly in patients with high-risk clinical features.

Study context

Population
Colombian patients aged ≥18 years with systemic lupus erythematosus (SLE) (2012 SLICC criteria) in the ARTMEDICA program, treated March 2011–August 2017mean follow-up 14.7 years
Participants
559 patients
Outcome
Organ damage accrual (SLICC/ACR DI) and damage-free survival
Methodological detailsregistry-based, multilevel generalized linear models, parametric survival models for interval-censored data
  • Registry-based
  • Multilevel generalized linear models
  • Parametric survival models for interval-censored data

Main finding

As reported in the abstract

Organ damage accrual and DFS

Mean SLICC/ACR Damage Index (SDI) at 15 years

1.24

95% CI 1.08–1.40

Mean SDI at 30 years

1.53

95% CI 1.16–1.90

Median organ damage-free survival (DFS), years

7.2

95% CI 5.8–8.5

Observational data: associations, not effects.

Further findings

Factors associated with faster damage accrual (mean annual change ratios (MACR) in SDI)

Myelopathy, MACR
2.24; 95%CI 1.26-3.98
Cellular casts, MACR
2.15; 95%CI 1.09-4.22
Seizures, MACR
1.82; 1.30-2.55
Disease activity, MACR
1.22; 95%CI 1.10-1.35

Relapses

Median number of relapses
3.5 (IQR: 1-8)

Original publication

Thirty-year trajectory of organ damage accrual and damage-free survival in Colombian patients with systemic lupus erythematosus: A registry-based retrospective follow-up study. Lupus. Published 29 October 2025. doi:10.1177/09612033251394176

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.